Veronika Siegl
Medical University of Graz
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Veronika Siegl.
Cancer Cell | 2013
Karine Pozo; Emely Castro-Rivera; Chunfeng Tan; Florian Plattner; Gert Schwach; Veronika Siegl; Douglas Meyer; Ailan Guo; Justin S. Gundara; Gabriel Mettlach; Edmond Richer; Jonathan A. Guevara; Li Ning; Anjali Gupta; Guiyang Hao; Li-Huei Tsai; Xiankai Sun; P. Antich; S. B. Sidhu; Bruce G. Robinson; Herbert Chen; Fiemu E. Nwariaku; Roswitha Pfragner; James A. Richardson; James A. Bibb
Medullary thyroid carcinoma (MTC) is a neuroendocrine cancer that originates from calcitonin-secreting parafollicular cells, or C cells. We found that Cdk5 and its cofactors p35 and p25 are highly expressed in human MTC and that Cdk5 activity promotes MTC proliferation. A conditional MTC mouse model was generated and corroborated the role of aberrant Cdk5 activation in MTC. C cell-specific overexpression of p25 caused rapid C cell hyperplasia leading to lethal MTC, which was arrested by repressing p25 overexpression. A comparative phosphoproteomic screen between proliferating and arrested MTC identified the retinoblastoma protein (Rb) as a crucial Cdk5 downstream target. Prevention of Rb phosphorylation at Ser807/Ser811 attenuated MTC proliferation. These findings implicate Cdk5 signaling via Rb as critical to MTC tumorigenesis and progression.
Molecular Medicine Reports | 2015
Victor Aguiriano-Moser; Bernhard Svejda; Zengxia Li; Sonja Sturm; Hermann Stuppner; Elisabeth Ingolic; Harald Höger; Veronika Siegl; Nathalie Meier-Allard; Anton Sadjak; Roswitha Pfragner
Medullary thyroid carcinoma (MTC) originates from the C-cells of the thyroid and is not sensitive to radiation or chemotherapy. Therefore, surgical removal of the tumor tissue in its entirety is the only curative treatment for MTC. The present study aimed to examine the potential mechanisms of action of extracts of Trailliaedoxa gracilis (TG; WW Smith & Forrest), a plant from the province of Sichuan, China, and of ursolic acid (UA), a pentacyclic triterpen present in TG, on the MTC-SK MTC cell line. A total of 13 TG fractions and UA were examined in vitro for their effects on cell morphology, cell number, proliferation and rates of apoptosis. Reverse transcription-quantitative polymerase chain reaction of nuclear factor-κB essential modifier (NEMO) was performed to delineate the role of the apoptotic pathway following treatment with UA. TG and UA were examined in vivo in xenotransplanted MTC-bearing severe combined immunodeficient mice. The TG fractions exhibited antiproliferative effects, with inhibition of mitochondrial activity in the tumor cells at concentrations, which caused no impairment of the normal control cells. The apoptotic rates of the MTC-SK cells treated with the TG fractions and UA were determined, in which no marked tumor inhibition was observed in the treated MTC-mice, and no change in the expression of NEMO was detected in the treated MTC-SK cells. The observation of early-onset activation of caspase 8 suggested that the responsible factor was linked to NEMO, an anti-apoptotic protein. However, no differences in the mRNA transcription levels of NEMO were detected in MTC-SK cells treated with UA, suggesting that this protein was not associated with the signal transducer and activator of transcription 3 pathway.
Pteridines | 2001
Karoline Vrecko; Roswitha Pfragner; Veronika Siegl; Konrad Schauenstein; Gilbert Reibnegger
Abstract The first human phaeochromocytorna cell line KNA was tested with regard to stimulation of dopamine biosynthesis by nicotinamide adenine dinucleotide (NADH). Differently from rat phaeochromocytoma cells - clone PC12, where NADH increased dopamine biosynthesis significantly, no stimulation in KNA cells was found. NADH is effective on speeding up the formation of the active cofactor tetrahydrobiopterin by a recycling pathway via the dihydropteridinreductase system. Another way of formation of tetrahydrobiopterin is the induction of de novo synthesis by cytokines such as interferon-y or by lipopolysaccharide via activation of GTP cyclohydrolase I, as shown in rnacrophages. Neither rat PC12 nor human KNA cells showed in vitro a stimulation of tetrahydrobiopterin de novo synthesis by interferon-y and/or lipopolysaccharide.
Anticancer Research | 2004
Beate Rinner; Veronika Siegl; Peter Pürstner; Thomas Efferth; Brigitte Brem; Harald Greger; Roswitha Pfragner
Anticancer Research | 2009
Roswitha Pfragner; Annemarie Behmel; Harald Höger; Alfred Beham; Elisabeth Ingolic; Ingeborg Stelzer; Bernhard Svejda; Victor Aguiriano Moser; Anna Christina Obenauf; Veronika Siegl; Oskar A. Haas; Bruno Niederle
Anticancer Research | 2010
Bernhard Svejda; Victor Aguiriano-Moser; Sonja Sturm; Harald Höger; Elisabeth Ingolic; Veronika Siegl; Hermann Stuppner; Roswitha Pfragner
Anticancer Research | 2009
Beate Rinner; Zeng Xia Li; Helga Susanne Haas; Veronika Siegl; Sonja Sturm; Hermann Stuppner; Roswitha Pfragner
Oncology Reports | 2007
Helga Susanne Haas; Roswitha Pfragner; Veronika Siegl; Elisabeth Ingolic; Elfgard Heintz; Elisabeth Schraml; Konrad Schauenstein
Anticancer Research | 2008
Zengxia Li; Sonja Sturm; Bernhard Svejda; Harald Höger; Elisabeth Schraml; Elisabeth Ingolic; Veronika Siegl; Hermann Stuppner; Roswitha Pfragner
International Journal of Oncology | 2005
Helga Susanne Haas; Roswitha Pfragner; Veronika Siegl; Elisabeth Ingolic; Elfgard Heintz; Konrad Schauenstein